| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 197,818 | 184,795 | 248,133 | 174,961 | | Cost of Revenue | 398,817 | (31,524) | 98,406 | (115,520) | | | Gross Profit | (200,999) | 216,319 | 149,727 | 290,481 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (186,480) | 180,324 | 71,599 | 206,636 | | Non Recurring |
-
|
-
|
-
| 145 | | Others | (37,954) | 19,040 | 18,914 | 74,805 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,435 | 16,955 | 59,214 | 8,895 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 23,435 | 16,955 | 59,214 | 8,895 | | Interest Expense | 2,769 | 3,095 | 3,074 | 4,441 | | Income Before Tax | 20,666 | 13,860 | 56,140 | 4,454 | | Income Tax Expense | 7,956 | 4,865 | 22,088 | 2,080 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,710 | 8,995 | 34,052 | 2,374 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,710 | 8,995 | 34,052 | 2,374 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,710 | $8,995 | $34,052 | $2,374 |
|
0.02% Nasdaq 0.00%
Income Statement
